Specific thrombin inhibitors for the development of anticoagulant

Technology offer: Specific thrombin inhibitors for the development of anticoagulant

Reference: TOES20130801002

Summary: A Spanish public research organization and a University from Venezuela have developed a new protein with inhibitory activity against thrombin. Compared to other thrombin inhibitors, the protein is most selective and could be used as anticoagulant reducing side effects related to these compounds. Pharmaceutical or biotech companies are sought for further development under a license agreement.

For more information click here.

Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.